 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Millennium Pharmaceuticals, Inc.
 |
Millennium Pharmaceuticals, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Funds: Fund investors eye biotech Aug 16 2001 09:33 AM PDT
Funds: Fund investors eye biotech Aug 16 2001 09:33 AM PDT
Tokyo's Nikkei hits 16-year low, Advantest weighs Aug 13 2001 12:37 AM PDT
Aventis, Millennium expand inflammatory disease JV Aug 13 2001 12:36 AM PDT
Applera to spend $75 million to develop own drugs Jul 24 2001 05:33 AM PDT
> More WIRE STORIES about this company
NEWS FROM THE STANDARD |
 |
Biotech: Desperate No More
Jun 27 2001 07:21 AM PDT
Celera Catches the Drug Bug
Jun 13 2001 04:27 PM PDT
PROFILE |
 |
Millennium Pharmaceuticals looks for the genetic basis of a disease to stop it at its roots. It develops treatments and diagnostics primarily for three disease targets: cancer, metabolic diseases, and inflammation. Millennium derives its revenue from research and development alliances with such companies as Bayer (27%; it owns about 10% of Millennium), Monsanto (22%), and American Home Products. With ILEX Oncology, the firm's LeukoSite subsidiary has developed CAMPATH, a potential leukemia treatment that has received FDA fast-track status. Other collaborations include Abbott Laboratories (for metabolic diseases), Eli Lilly (cancer and cardiovascular disease), and Becton Dickinson (cancer diagnostics).
COMPETITION |
 |
Amgen Inc. (AMGN)
Chiron Corporation (CHIR)
Genentech, Inc. (DNA)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 196.30
1-Yr. Sales Growth: 6.9%
Employees: 1,330
Revenue per employee: $147,593.98
KEY PEOPLE |
 |
Mark J. Levin
CEO
Kevin P. Starr
CFO
CONTACT INFO |
 |
75 Sidney St.
Cambridge, MA 02139
US
Phone: 617-679-7000
Fax: 617-374-9379
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |